Anagenics Limited
ASX: AN1.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Michael Worner
- Employees
- 11
- Headquarters
- Sydney, Australia
- IPO year
- 2005
- Market cap
- A$2.6M
- Website
- https://anagenics.com
Loading AN1…
Loading profile data…Frequently asked questions about AN1
What does Anagenics Limited (AN1.AX) do?
Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, incl...
Where does AN1.AX trade?
Anagenics Limited (AN1.AX) trades on the Australian Securities Exchange.
What sector is AN1.AX in?
Anagenics Limited (AN1.AX) operates in the Consumer Defensive sector, specifically in the Household & Personal Products industry.
Who is the CEO of Anagenics Limited?
Michael Worner is the chief executive officer of Anagenics Limited (AN1.AX).
Where is Anagenics Limited headquartered?
Anagenics Limited is headquartered in Australia.
Does AN1.AX pay a dividend?
Anagenics Limited (AN1.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AN1.AX go public?
Anagenics Limited (AN1.AX) completed its initial public offering in 2005.